Financhill
Back

EyePoint Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Buy
64

EYPT
EyePoint Pharmaceuticals

Last Price:
9.46
Seasonality Move:
-10.5%
Sell
26

NBY
NovaBay Pharmaceuticals

Last Price:
0.51
Seasonality Move:
-14.79%
Buy
64
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $8.91. The Score for EYPT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • EYPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.51. The Score for NBY is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $8.91
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 53.32 Buy
Chaikin Money Flow: -111904 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.02 - 9.02) Buy
Bollinger Bands (100): (7.51 - 12.45) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 38.38 Sell
Chaikin Money Flow: -38478 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.47 - 0.53) Buy
Bollinger Bands (100): (0.61 - 3.39) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.63 Buy
20-day SMA: 8.68 Buy
50-day SMA: 8.89 Buy
200-day SMA: 16.42 Sell
8-day EMA: 8.71 Buy
20-day EMA: 8.63 Buy
50-day EMA: 9.07 Sell
200-day EMA: 12.38 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.48 Buy
20-day SMA: 0.49 Buy
50-day SMA: 0.89 Sell
200-day SMA: 3.84 Sell
8-day EMA: 0.49 Buy
20-day EMA: 0.53 Sell
50-day EMA: 0.97 Sell
200-day EMA: 8.42 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):